Oral Abstract: IBCL-098 TRANSCEND FL: Phase II Study Results of Lisocabtagene Maraleucel (Liso-Cel) in Patients With R/R Follicular Lymphoma (FL)
Clinical Lymphoma, Myeloma & Leukemia（2023）
关键词
IBCL,indolent NHL,relapsed or refractory,follicular lymphoma,liso-cel,third line or later,Phase II
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要